AGF Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2M | Buy |
587,740
+8,021
| +1% | +$371K | 0.12% | 135 |
|
|
2025
Q1 | $35.4M | Sell |
579,719
-27,345
| -5% | -$1.67M | 0.19% | 123 |
|
|
2024
Q4 | $34.3M | Buy |
607,064
+45,901
| +8% | +$2.6M | 0.17% | 126 |
|
|
2024
Q3 | $29M | Buy |
561,163
+4,830
| +0.9% | +$250K | 0.15% | 139 |
|
|
2024
Q2 | $23.1M | Sell |
556,333
-21,187
| -4% | -$880K | 0.13% | 140 |
|
|
2024
Q1 | $31.3M | Sell |
577,520
-17,400
| -3% | -$944K | 0.17% | 137 |
|
|
2023
Q4 | $30.5M | Buy |
594,920
+7,904
| +1% | +$406K | 0.18% | 132 |
|
|
2023
Q3 | $34.1M | Sell |
587,016
-14,025
| -2% | -$814K | 0.24% | 115 |
|
|
2023
Q2 | $38.4M | Sell |
601,041
-14,583
| -2% | -$933K | 0.28% | 105 |
|
|
2023
Q1 | $42.7M | Sell |
615,624
-7,948
| -1% | -$551K | 0.29% | 102 |
|
|
2022
Q4 | $44.9M | Buy |
+623,572
| New | +$44.9M | 0.33% | 90 |
|